259
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Genetics in Ocular Inflammation—Basic Principles

, PhD & , PhD
Pages 10-18 | Received 26 Oct 2010, Accepted 23 Nov 2010, Published online: 20 Jan 2011

REFERENCES

  • Antoniou AC, Chenevix-Trench G. Common genetic variants and cancer risk in Mendelian cancer syndromes. Curr Opin Genet Dev. Jun 2010;20(3):299–307.
  • Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol. Aug 2005;14(3-4):175–182.
  • Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. Aug 1982;94(2):147–158.
  • Bonfioli AA, Orefice F. Behcet′s disease. Semin Ophthalmol. Jul–Sep 2005;20(3):199–206.
  • Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. Jul–Aug 2005;50(4):364–388.
  • Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. Jan 1997;123(1):70–75.
  • Kilmartin DJ, Wilson D, Liversidge J, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol. Mar 2001;85(3):281–286.
  • Cuccia Belvedere M, Martinetti M, de Paoli F, et al. Genetic heterogeneity in uveitis. Dis Markers. Oct 1986;4(3):243–246.
  • Szpak Y, Vieville JC, Tabary T, et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A. Feb 27 2001;98(5):2572–2576.
  • Pennesi G, Mattapallil MJ, Sun SH, et al. A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest. Apr 2003;111(8):1171–1180.
  • Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. Nov–Dec 2001;46(3):195–208.
  • Gorrono-Echebarria MB, Calvo-Arrabal MA, Albarran F, Alvarez-Mon M. The tuberculointerstitial nephritis and uveitis (TINU) syndrome is associated with HLA-DR14 in Spanish patients. Br J Ophthalmol. Aug 2001;85(8):1010–1011.
  • Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. Feb 2003;44(2):653–657.
  • Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. Jul-Sep 2005;20(3):183–190.
  • Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behcet′s disease. Arch Ophthalmol. Sep 1982;100(9):1455–1458.
  • Ota M, Mizuki N, Katsuyama Y, et al. The critical region for Behcet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet. May 1999;64(5):1406–1410.
  • Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behcet′s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. Nov 2000;41(12):3702–3708.
  • Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behcet′s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. Mar 2003;48(3):807–813.
  • Gul A, Uyar FA, Inanc M, et al. A weak association of HLA-B*2702 with Behcet′s disease. Genes Immun. Sep 2002;3(6):368–372.
  • Gao X, O′Brien TR, Welzel TM, et al. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS. Jul 31 2010;24(12):1835–1840.
  • Feitsma AL, Worthington J, van der Helm-van Mil AH, et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc Natl Acad Sci U S A. Dec 11 2007;104(50):19966–19970.
  • Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet′s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. Sep 1999;54(3):213–220.
  • Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infliximab on sight-threatening panuveitis in Behcet′s disease. Lancet. Jul 28 2001;358(9278):295–296.
  • El-Shabrawi Y, Wegscheider BJ, Weger M, et al. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology. Apr 2006;113(4):695–700.
  • Kuo NW, Lympany PA, Menezo V, et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci. May 2005;46(5):1565–1571.
  • Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet′s disease. Rheumatology (Oxford). Jul 2003;42(7):860–864.
  • Stanford MR, Vaughan RW, Kondeatis E, et al. Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom? Br J Ophthalmol. Aug 2005;89(8):1013–1016.
  • Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens. Jan 2004;63(1):41–45.
  • Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci. Nov 2005;46(11):4245–4250.
  • Wallace GR, Kondeatis E, Vaughan RW, et al. IL-10 genotype analysis in patients with Behcet′s disease. Hum Immunol. Feb 2007;68(2):122–127.
  • Atan D, Fraser-Bell S, Plskova J, et al. Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Vis Sci. Aug 2010;51(8):4133–4142.
  • Broeckel U, Schork NJ. Identifying genes and genetic variation underlying human diseases and complex phenotypes via recombination mapping. J Physiol. Jan 1 2004;554(Pt 1):40–45.
  • Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. Jul 8 2010;363(2):166–176.
  • Hindorff LA JH, Hall PN, Mehta JP, and Manolio TA. A Catalog of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies. Accessed [07/10/2010].
  • Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behcet′s disease using a genome-wide association study. Arthritis Res Ther. 2009;11(3):R66.
  • Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet′s disease. Nat Genet. Aug 2010;42(8):698–702.
  • Kurata R, Nakaoka H, Tajima A, et al. TRIM39 and RNF39 are associated with Behcet′s disease independently of HLA-B *51 and -A *26. Biochem Biophys Res Commun. Sep 27 2010.
  • Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet′s disease susceptibility loci. Nat Genet. Aug 2010;42(8):703–706.
  • Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. May 2006;116(5):1218–1222.
  • Paunovic V, Carroll HP, Vandenbroeck K, Gadina M. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity. Rheumatology (Oxford). Jun 2008;47(6):771–776.
  • Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. Feb 2008;14(2):194–198.
  • Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. May 17 2005;102(20):7227–7232.
  • Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. Apr 15 2005;308(5720):385–389.
  • Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. Sep 2005;77(3):389–407.
  • McKay GJ, Dasari S, Patterson CC, Chakravarthy U, Silvestri G. Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol Vis. 2010;16:194–199.
  • Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum. Jan 2005;52(1):269–274.
  • Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. May 2007;39(5):596–604.
  • Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet. Jan 2009;10(1):43–55.
  • Baranathan V, Stanford MR, Vaughan RW, et al. The association of the PTPN22 620W polymorphism with Behcet′s disease. Ann Rheum Dis. Nov 2007;66(11):1531–1533.
  • Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn′s disease. Nat Genet. Aug 2008;40(8):955–962.
  • Bye L, Modi N, Stanford MR, et al. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens. Jul 2008;72(1):49–53.
  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. Jun 7 2007;447(7145):661–678.
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. Dec 1977;74(12):5463–5467.
  • Hutchison CA, 3rd. DNA sequencing: bench to bedside and beyond. Nucleic Acids Res. 2007;35(18):6227–6237.
  • Ansorge WJ. Next-generation DNA sequencing techniques. N Biotechnol. Apr 2009;25(4):195–203.
  • Schuster SC. Next-generation sequencing transforms today′s biology. Nat Methods. Jan 2008;5(1):16–18.
  • Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. Jan 2010;11(1):31–46.
  • Li Z, Liu B, Maminishkis A, et al. Gene expression profiling in autoimmune noninfectious uveitis disease. J Immunol. Oct 1 2008;181(7):5147–5157.
  • Shanley DP, Aw D, Manley NR, Palmer DB. An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. Jul 2009;30(7):374–381.
  • Panda A, Arjona A, Sapey E, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. Jul 2009;30(7):325–333.
  • Williams GC. Pleiotropy, natural selection and the evolution of senescence. Evolution. 1957;11:398–411.
  • Ferwerda B, Alonso S, Banahan K, et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci U S A. Jun 23 2009;106(25):10272–10277.
  • Dieker J, Muller S. Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol. Aug 2010;39(1):78–84.
  • Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451–481.
  • Moore JH, Williams SM. Epistasis and its implications for personal genetics. Am J Hum Genet. Sep 2009;85(3):309–320.
  • Ferwerda B, McCall MB, Alonso S, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A. Oct 16 2007;104(42):16645–16650.
  • Mitchison NA, Muller B, Segal RM. Natural variation in immune responsiveness, with special reference to immunodeficiency and promoter polymorphism in class II MHC genes. Hum Immunol. Feb 2000;61(2):177–181.
  • Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature. Apr 29 2010;464(7293):1351–1356.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.